Physician profile
James Wilder
NPI 1386615961
$1,867.22
in general payments reported to CMS, 2019-2025
19 companies · $647 in 2025
The $647 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $108 · 2021: $17.17 · 2022: $350 · 2023: $313 · 2024: $95.92 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985 · Education: $71.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.64 |
| Education | $71.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $445.03 | 2022-2025 | Miebo, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $259.13 | 2019-2020 | |
| Alcon Vision LLC | $212.66 | 2019-2025 | Argos, Clareon |
| Tarsus Pharmaceuticals, INC. | $192.31 | 2024-2025 | Xdemvy |
| Apellis Pharmaceuticals, INC. | $124.99 | 2023 | Syfovre |
| Dompe US, INC. | $122.38 | 2024-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $75.12 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $61.84 | 2020-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $57.81 | 2022 | |
| Glaukos Corporation | $46.82 | 2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $39.75 | 2020-2023 | |
| Rxsight INC | $35.77 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Allergan, INC. | $35.76 | 2020-2022 | |
| Biotissue Holdings INC. | $34.66 | 2025 | |
| Harrow Eye, LLC | $31.86 | 2025 | Vevye |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $26.94 | 2023 | Rayone Aspheric, Rayone Spheric, Omidria |
| Oyster Point Pharma, INC. | $24.94 | 2023 | Tyrvaya |
| Astellas Pharma US INC | $21.36 | 2025 | Izervay |
| Abbvie INC. | $18.09 | 2023 | Xen Glaucoma Treatment System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wilder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.